Cargos activos de Shengkan Jin
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Mito BioPharm LLC
 Mito BioPharm LLC Pharmaceuticals: MajorHealth Technology Mito BioPharm LLC is an American pharmaceutical company that focuses on developing therapies for non-alcoholic fatty liver disease (NAFLD), specifically non-alcoholic steatohepatitis (NASH) and type 2 diabetes. NAFLD is a range of conditions that start with fat accumulation in the liver and can progress to inflammation, fibrosis, cirrhosis, and even liver cancer. Mito BioPharm's drug discovery pipeline and intellectual property are aimed at addressing these conditions. | Director/Miembro de la Junta | 01/01/2012 | - |
| Director Técnico/Científico/I+D | 01/01/2012 | - | |
| Fundador | 01/01/2012 | - |
Historial de carrera de Shengkan Jin
Estadísticas
Internacional
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectorial
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Mito BioPharm LLC
Mito BioPharm LLC Pharmaceuticals: MajorHealth Technology Mito BioPharm LLC is an American pharmaceutical company that focuses on developing therapies for non-alcoholic fatty liver disease (NAFLD), specifically non-alcoholic steatohepatitis (NASH) and type 2 diabetes. NAFLD is a range of conditions that start with fat accumulation in the liver and can progress to inflammation, fibrosis, cirrhosis, and even liver cancer. Mito BioPharm's drug discovery pipeline and intellectual property are aimed at addressing these conditions. | Health Technology |
- Bolsa de valores
- Insiders
- Shengkan Jin
- Experiencia
